Cold X5 Hairlaser Used to Treat Male Androgenic Alopecia and Hair Growth: An Uncontrolled Pilot Study

February 2014 in “ BMC Research Notes ”

Kenneth Blum, David K. Han, Margaret A. Madigan, Raquel Lohmann, Eric R. Braverman

X5 Hairlaser androgenic alopecia hair growth Fitzpatrick skin type AGA

TLDR The X5 Hairlaser might help treat male hair loss, but more research is needed.

In 2014, an uncontrolled pilot study investigated the efficacy of the X5 Hairlaser™ device for treating male androgenic alopecia (AGA) in 48 subjects over a 26-week period. The study initially enrolled 119 participants, but due to issues with the sham control device, only the 70 who received the actual treatment were focused on, and of those, 48 completed all visits. The results showed a statistically significant increase in mean hair counts from baseline to the end of the study (p-value <0.0001), with no significant association found between hair growth and variables such as Fitzpatrick skin type or age group. The study concluded that the X5 Hairlaser device could potentially be effective for treating male AGA, but the lack of a control group and high variability in results indicated the need for further research. No severe adverse events were reported during the study. The trial was registered under NCT02067260.

View this study on bmcresnotes.biomedcentral.com →

Discuss this study in the Community →

Research cited in this study

16 / 16 results

research Genetic Variants at 20p11 Confer Risk to Androgenetic Alopecia in the Chinese Han Population

9 citations, August 2013 in “PLOS ONE”

Genetic variants at 20p11 increase baldness risk in Chinese Han people.

research New Investigational Drugs for Androgenetic Alopecia

48 citations, April 2013 in “Expert Opinion on Investigational Drugs”

Possible new treatments for common hair loss include drugs, stem cells, and improved transplants.

research Low-Level Light Therapy for Androgenetic Alopecia: A 24-Week, Randomized, Double-Blind, Sham Device-Controlled Multicenter Trial

106 citations, April 2013 in “Dermatologic Surgery”

Low-level light therapy safely improves hair growth and thickness for androgenetic alopecia.

research Finasteride, 1 Mg Daily Administration on Male Androgenetic Alopecia in Different Age Groups: 10-Year Follow-Up

44 citations, July 2011 in “Dermatologic Therapy”

Finasteride effectively increases hair growth in men with AGA, works better for those over 30, and may cause some side effects.

research Evidence for Two Independent Functional Variants for Androgenetic Alopecia Around the Androgen Receptor Gene

26 citations, November 2010 in “Experimental Dermatology”

Two gene areas linked to male pattern baldness found, more research needed.

research Androgenic Alopecia: A Counterproductive Outcome of the Anabolic Effect of Androgens

11 citations, May 2009 in “Medical Hypotheses”

Male pattern baldness is an unintended side effect of the body's use of androgens for muscle growth, especially in those genetically prone to it.

research HairMax LaserComb Laser Phototherapy Device in the Treatment of Male Androgenetic Alopecia

160 citations, January 2009 in “Clinical Drug Investigation”

HairMax LaserComb® effectively promotes hair growth and stops hair loss in males with androgenetic alopecia, with no serious side effects.

research EDA2R Is Associated With Androgenetic Alopecia

82 citations, September 2008 in “Journal of Investigative Dermatology”

EDA2R gene linked to hair loss.

research Genome-Wide Scan and Fine-Mapping Linkage Study of Androgenetic Alopecia Reveals a Locus on Chromosome 3q26

62 citations, March 2008 in “American Journal of Human Genetics”

Hair loss gene found on chromosome 3q26.

research Disruption of P2RY5, an Orphan G Protein–Coupled Receptor, Underlies Autosomal Recessive Woolly Hair

210 citations, February 2008 in “Nature genetics”

Mutations in the P2RY5 gene cause autosomal recessive woolly hair.

research Human Hair Follicles Contain Two Forms of ATP-Sensitive Potassium Channels, Only One Sensitive to Minoxidil

102 citations, February 2008 in “The FASEB Journal”

One minoxidil-sensitive potassium channel exists in human hair follicles.

Baldness And The Androgen Receptor: The AR Polyglycine Repeat Polymorphism Does Not Confer Susceptibility To Androgenetic Alopecia

research Baldness And The Androgen Receptor: The AR Polyglycine Repeat Polymorphism Does Not Confer Susceptibility To Androgenetic Alopecia

60 citations, January 2007 in “Human Genetics”

AR polyglycine repeat doesn't cause baldness.

research Genetic Variation in the Human Androgen Receptor Gene Is the Major Determinant of Common Early-Onset Androgenetic Alopecia

195 citations, July 2005 in “American Journal of Human Genetics”

Genetic variation in the androgen receptor gene mainly causes early-onset hair loss, with maternal inheritance playing a key role.

research Hormonal Profile of Men with Premature Balding

29 citations, February 2004 in “Experimental and Clinical Endocrinology & Diabetes”

Men with early balding often have hormone levels similar to women with polycystic ovary syndrome.

research Finasteride in the Treatment of Men with Androgenetic Alopecia

581 citations, October 1998 in “Journal of The American Academy of Dermatology”

Finasteride safely and effectively treats male pattern hair loss, but may cause reversible sexual issues and harm male fetuses.

research Hair Diseases

28 citations, September 1998 in “Medical Clinics of North America”

Most hair loss can be diagnosed with patient history and physical exam, and a few common types make up most cases.

Related Research

1 / 1 results

research Cold X5 Hairlaser Used to Treat Male Androgenic Alopecia and Hair Growth: An Uncontrolled Pilot Study

15 citations, February 2014 in “BMC Research Notes”

The X5 Hairlaser might help treat male hair loss, but more research is needed.